TY - JOUR
T1 - Autophagy as a molecular target for cancer treatment
AU - Kocaturk, Nur Mehpare
AU - Akkoc, Yunus
AU - Kig, Cenk
AU - Bayraktar, Oznur
AU - Gozuacik, Devrim
AU - Kutlu, Ozlem
N1 - This work was supported by Scientific and Technological Research Council of Turkey (TUBITAK)-1001 Grant number: 114Z836 . YA is supported by TUBITAK-BIDEB 2211 Scholarships for his PhD studies.
Publisher Copyright:
© Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/6/15
Y1 - 2019/6/15
N2 - Autophagy is an evolutionarily conserved catabolic mechanism, by which eukaryotic cells recycle or degrades internal constituents through membrane-trafficking pathway. Thus, autophagy provides the cells with a sustainable source of biomolecules and energy for the maintenance of homeostasis under stressful conditions such as tumor microenvironment. Recent findings revealed a close relationship between autophagy and malignant transformation. However, due to the complex dual role of autophagy in tumor survival or cell death, efforts to develop efficient treatment strategies targeting the autophagy/cancer relation have largely been unsuccessful. Here we review the two-faced role of autophagy in cancer as a tumor suppressor or as a pro-oncogenic mechanism. In this sense, we also review the shared regulatory pathways that play a role in autophagy and malignant transformation. Finally, anti-cancer therapeutic agents used as either inhibitors or inducers of autophagy have been discussed.
AB - Autophagy is an evolutionarily conserved catabolic mechanism, by which eukaryotic cells recycle or degrades internal constituents through membrane-trafficking pathway. Thus, autophagy provides the cells with a sustainable source of biomolecules and energy for the maintenance of homeostasis under stressful conditions such as tumor microenvironment. Recent findings revealed a close relationship between autophagy and malignant transformation. However, due to the complex dual role of autophagy in tumor survival or cell death, efforts to develop efficient treatment strategies targeting the autophagy/cancer relation have largely been unsuccessful. Here we review the two-faced role of autophagy in cancer as a tumor suppressor or as a pro-oncogenic mechanism. In this sense, we also review the shared regulatory pathways that play a role in autophagy and malignant transformation. Finally, anti-cancer therapeutic agents used as either inhibitors or inducers of autophagy have been discussed.
KW - Autophagy
KW - Cancer
KW - Therapeutic agents
UR - http://www.scopus.com/inward/record.url?scp=85064667322&partnerID=8YFLogxK
U2 - 10.1016/j.ejps.2019.04.011
DO - 10.1016/j.ejps.2019.04.011
M3 - Article
C2 - 30981885
AN - SCOPUS:85064667322
SN - 0928-0987
VL - 134
SP - 116
EP - 137
JO - European Journal of Pharmaceutical Sciences
JF - European Journal of Pharmaceutical Sciences
ER -